Curis, Inc. (CRIS): Price and Financial Metrics

CRIS POWR Grades

• Value is the dimension where CRIS ranks best; there it ranks ahead of 51.34% of US stocks.
• The strongest trend for CRIS is in Momentum, which has been heading down over the past 52 weeks.
• CRIS ranks lowest in Sentiment; there it ranks in the 1st percentile.

CRIS Stock Summary

• Curis Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 11.69% of US listed stocks.
• CRIS's price/sales ratio is 65.2; that's higher than the P/S ratio of 95.91% of US stocks.
• Curis Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -24.83%, greater than the shareholder yield of only 11.83% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Curis Inc are LOGC, SILC, VXRT, GSIT, and SVRA.
• CRIS's SEC filings can be seen here. And to visit Curis Inc's official web site, go to www.curis.com.

CRIS Valuation Summary

• In comparison to the median Healthcare stock, CRIS's price/sales ratio is 597.8% higher, now standing at 79.2.
• CRIS's price/sales ratio has moved down 161 over the prior 243 months.
• CRIS's EV/EBIT ratio has moved down 21.2 over the prior 243 months.

Below are key valuation metrics over time for CRIS.

CRIS Growth Metrics

• Its year over year net income to common stockholders growth rate is now at 5.76%.
• Its 4 year price growth rate is now at -90.58%.
• The 5 year net cashflow from operations growth rate now stands at 17.64%.

CRIS's revenue has moved up $2,362,593 over the prior 67 months.

The table below shows CRIS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	10.241	-31.43	-34.256
2021-03-31	10.315	-29.902	-30.126
2020-12-31	10.835	-25.739	-29.908
2020-09-30	11.098	-25.623	-30.999
2020-06-30	11.212	-27.628	-31.461
2020-03-31	10.946	-24.617	-31.966

CRIS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CRIS has a Quality Grade of C, ranking ahead of 40.35% of graded US stocks.
• CRIS's asset turnover comes in at 0.066 -- ranking 303rd of 681 Pharmaceutical Products stocks.
• YMTX, VTRS, and KDNY are the stocks whose asset turnover ratios are most correlated with CRIS.

The table below shows CRIS's key quality metrics over time.